BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bunsawat K, Ratchford SM, Alpenglow JK, Park SH, Jarrett CL, Stehlik J, Smith AS, Richardson RS, Wray DW. Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction. J Appl Physiol (1985) 2021;130:256-68. [PMID: 33211601 DOI: 10.1152/japplphysiol.00454.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Robinson AT, Wenner MM, Bunsawat K, Watso JC, Giersch GEW, Charkoudian N. When it's time for the sex talk, words matter. Am J Physiol Heart Circ Physiol 2022;322:H66-70. [PMID: 34797173 DOI: 10.1152/ajpheart.00556.2021] [Reference Citation Analysis]
2 Bunsawat K, Ratchford SM, Alpenglow JK, Stehlik J, Smith AS, Richardson RS, Wray DW. Sympathoinhibitory effect of sacubitril-valsartan in heart failure with reduced ejection fraction: A pilot study. Auton Neurosci 2021;235:102834. [PMID: 34186274 DOI: 10.1016/j.autneu.2021.102834] [Reference Citation Analysis]